Benzinga's Top Initiations

Analysts at Cantor Fitzgerald initiated coverage on Ross Stores, Inc. ROST with a Hold rating. The target price for Ross Stores is set to $110. Ross Stores' shares closed at $102.29 yesterday. Analysts at Wunderlich initiated coverage on Jernigan Capital Inc. JCAP with a Buy rating. The target price for Jernigan Capital is set to $25. Jernigan Capital's shares closed at $21.30 yesterday. Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc RGLS with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics' shares closed at $17.18 yesterday. Stifel Nicolaus initiated coverage on Summit Materials Inc SUM with a Buy rating. The target price for Summit Materials is set to $28. Summit Materials' shares closed at $24.22 yesterday. FBR Capital initiated coverage on Genocea Biosciences Inc GNCA with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences' shares closed at $12.93 yesterday. Analysts at FBR Capital initiated coverage on Zafgen Inc ZFGN with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares closed at $36.58 yesterday. Raymond James initiated coverage on Community Bank System, Inc. CBU with a Market Perform rating. Community Bank System's shares closed at $35.64 yesterday. Analysts at FBR Capital initiated coverage on Biocryst Pharmaceuticals, Inc. BCRX with a Outperform rating. The target price for Biocryst Pharmaceuticals is set to $18. Biocryst Pharmaceuticals' shares closed at $10.29 yesterday. FBR Capital initiated coverage on Corcept Therapeutics Incorporated CORT with a Outperform rating. The target price for Corcept Therapeutics is set to $12. Corcept Therapeutics' shares closed at $5.98 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!